Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women
Background: Trivalent influenza vaccine (TIV) has been recommended for pregnant women in Australia for more than a decade and funded since 2009, yet vaccination coverage remains low. Misperceptions of the safety of TIV in pregnancy have been identified as a major contributor to low vaccination rates...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Wiley-Blackwell Publishing Asia
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/27411 |